| Dr Valerie Cynthia Altavas, MD | |
|
655 Euclid Ave, Suite 302 304, National City, CA 91950-2957 | |
| (619) 472-4575 | |
| (619) 472-4530 |
| Full Name | Dr Valerie Cynthia Altavas |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 46 Years |
| Location | 655 Euclid Ave, National City, California |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245231174 | NPI | - | NPPES |
| 01656931 | Medicaid | NY | |
| MDB334 | Other | NY | PREFERRED CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 201309 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paradise Valley Hospital | National city, CA | Hospital |
| Scripps Mercy Hospital | San diego, CA | Hospital |
| Sharp Chula Vista Medical Center | Chula vista, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valerie C Altavas Md A Medical Corporation | 5294826566 | 3 |
News Archive
It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.
Counterintuitive Findings Offer New Insights into Parkinson Disease Pathology, According to New Research Published in The American Journal of Pathology
Post-hoc analysis of randomized trial results shows that treating individuals with Type 2 diabetes with a combination of phentermine and topiramate increases their achievement of goals recommended for the management of their condition.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 1 days ago
| Entity Name | Valerie C Altavas Md A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770787004 PECOS PAC ID: 5294826566 Enrollment ID: O20070801000545 |
News Archive
It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.
Counterintuitive Findings Offer New Insights into Parkinson Disease Pathology, According to New Research Published in The American Journal of Pathology
Post-hoc analysis of randomized trial results shows that treating individuals with Type 2 diabetes with a combination of phentermine and topiramate increases their achievement of goals recommended for the management of their condition.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Valerie Cynthia Altavas, MD 1440 Hotel Cir N, Apt 371, San Diego, CA 92108-2906 Ph: (619) 501-9110 | Dr Valerie Cynthia Altavas, MD 655 Euclid Ave, Suite 302 304, National City, CA 91950-2957 Ph: (619) 472-4575 |
News Archive
It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.
Counterintuitive Findings Offer New Insights into Parkinson Disease Pathology, According to New Research Published in The American Journal of Pathology
Post-hoc analysis of randomized trial results shows that treating individuals with Type 2 diabetes with a combination of phentermine and topiramate increases their achievement of goals recommended for the management of their condition.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 1 days ago
Dr. Dottie Ann Sazon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 655 Euclid Ave, Suite #206, National City, CA 91950 Phone: 619-267-3188 Fax: 619-267-3388 | |
Arwinnah Bautista, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1430 E Plaza Blvd Ste E19a, National City, CA 91950 Phone: 619-434-2813 Fax: 855-631-3720 | |
Dr. Ira Richard Braverman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 Euclid Avenue, Suite 201, National City, CA 91950 Phone: 619-267-8181 Fax: 619-479-6750 | |
Andrew J Alongi, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2345 E 8th St, Suite 101, National City, CA 91950 Phone: 619-779-7905 Fax: 619-779-7906 | |
Dr. Troy Huvilla Niguidula, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 610 Euclid Avenue, Suite 201, National City, CA 91950 Phone: 619-267-8181 Fax: 619-479-6750 | |
Dr. Man Hung Jasmine Chow, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 655 Euclid Ave, 210, National City, CA 91950 Phone: 619-475-4004 Fax: 619-470-2793 |